Related Experiment Video
Updated: Mar 18, 2026

Author Spotlight: Implementation of BIVA for Analyzing Disease Risk Factors in Patients with Low Body Cell Mass
Published on: July 14, 2023
Implementing an Electronic Medical Record-Based Reminder for Cardiovascular Risk Screening in Rheumatoid Arthritis
Ayobami T Akenroye1, Anand A Kumthekar1, Michail K Alevizos1
1Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, New York.
Insights
An electronic medical record reminder did not improve cardiovascular disease (CVD) risk screening for rheumatoid arthritis (RA) patients. Further research is needed to overcome barriers and educate on RA-related CVD risks.
Area of Science:
- Rheumatology
- Cardiology
- Health Informatics
Background:
- Cardiovascular disease (CVD) is a leading cause of mortality in rheumatoid arthritis (RA) patients.
- Systematic CVD risk assessment is often inadequate in RA management.
- Tertiary care centers face challenges in integrating CVD risk screening into routine RA care.
Purpose of the Study:
- To evaluate the effectiveness of an electronic medical record (EMR)-based reminder system.
- To assess the impact of EMR reminders on CVD risk screening by rheumatologists and primary care providers in RA patients.
- To determine changes in lipid screening, blood pressure, and obesity rates post-intervention.
Main Methods:
- An EMR-based reminder system was implemented in December 2013 for RA patients (ICD-9 code 714.0).
- The reminder included key cardiovascular risk factors: body mass index, blood pressure, and lipid profiles.
- Lipid screening rates, BP, and obesity were compared pre- and post-implementation; logistic regression identified screening predictors.
Main Results:
- Lipid screening rates were 50% pre-implementation and 46% post-implementation (P=0.58), showing no significant improvement.
- No significant improvements were observed in blood pressure or obesity rates after the EMR reminder implementation.
- Older age and a history of diabetes mellitus were associated with higher odds of lipid screening post-intervention.
Conclusions:
- The implemented EMR reminder did not enhance cardiovascular disease risk screening among rheumatoid arthritis patients.
- Barriers to effective CVD screening in RA require further investigation.
- Educational initiatives for patients and providers regarding RA-associated CVD risks are necessary.
Objective:
Although cardiovascular disease (CVD) is the leading cause of death among individuals with rheumatoid arthritis (RA), CVD risks are not being assessed frequently and systematically in RA. We implemented an electronic medical record (EMR)-based reminder in a tertiary care center and assessed the effects of this intervention on CVD risk screening by rheumatologists and primary care providers.
Methods:
The EMR reminder was implemented in December 2013 and included the most recent value and target ranges for body mass index, blood pressure (BP), and lipid profiles. It was displayed for every rheumatology and primary care visit for all patients with the International Classification of Diseases, Ninth Revision code for RA (714.0). Lipid screening rates, as well as changes in BP and obesity rates were compared pre- and postimplementation. Factors associated with lipid screening postimplementation were assessed using multivariate logistic regression.
Results:
A total of 138 and 112 RA patients were seen in the outpatient clinics pre- and postimplementation, respectively. The demographic characteristics were similar in the pre- and postimplementation groups. Lipid screening rates were 50% preimplementation and 46% postimplementation (P = 0.58). There were no significant improvements in BP or obesity rates postimplementation. Factors associated with the higher odds of lipid screening included older age and history of diabetes mellitus.
Conclusion:
Implementing an EMR reminder did not improve CVD risk screening among RA patients. Future research is needed to identify and address barriers to CVD screening, and to educate patients and providers about RA-related risks.
Related Concept Videos
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease IV: Nursing Management
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis III: Management

